Illumina said this week that the US Food and Drug Administration has granted it breakthrough device designation for its pan-cancer assay, which is currently in ...
Updated: 01/25/2019 02:30P
Sangray, developed by Hitachi, a Japanese-based medical device company, is a medical device used to prevent transfusion-related graft-versus-host disease, a disease that can occur after transfusion, by irradiating a blood bag for transfusion with X-rays.
Updated: 11/20/2018 10:57P